VanEck Biotech ETF
BBH
BBH
79 hedge funds and large institutions have $211M invested in VanEck Biotech ETF in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less funds holding
Funds holding: 86 → 79 (-7)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
79
Holding in Top 10
–
Calls
$3.8M
Puts
$1.07M
Top Buyers
| 1 | +$28.8M | |
| 2 | +$6.06M | |
| 3 | +$4.65M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.08M |
| 5 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
+$1.81M |
Top Sellers
| 1 | -$4.79M | |
| 2 | -$2.63M | |
| 3 | -$2.5M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.74M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.72M |